Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1) ER/PR unknown status 2) Evidence of distant metastasis 3) Past history of other hormonal therapy 4) Patients with uncontrolled cardiac disease 5) Other significant malignancies within the past 3 years or other serious illnesses like uncontrolled diabetes or chronic renal disease 6) Patients with diseases that require chronic intake of drugs that interfere with bone metabolism
Exclusion criteria
Exclusion criteria: 1) ER/PR unknown status 2) Evidence of distant metastasis 3) Past history of other hormonal therapy 4) Patients with uncontrolled cardiac disease 5) Other significant malignancies within the past 3 years or other serious illnesses like uncontrolled diabetes or chronic renal disease 6) Patients with diseases that require chronic intake of drugs that interfere with bone metabolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is to understand the incidence of osteoporosis in Indian postmenopausal population and effect of Aromatase inhibitors on the incidence of osteoporosisTimepoint: A baseline DEXA scan will be obtained as a part of routine work up before stating AIs A repeat baseline BMD scan will be done at 12 months and at 2 years after starting AIs | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactDr Jessicka Shah
Tata Memorial Hospital
Outcome results
None listed